Researchers studied a specific gene variant called PALB2 in over 600,000 adults from two large population databases. They wanted to understand how common this variant is and whether it affects cancer risk and overall survival. The study included adults from the UK Biobank and Geisinger MyCode programs who had their genes analyzed.
They found that people with the PALB2 variant had higher odds of developing several cancers, including breast and pancreatic cancer. These individuals also had higher overall mortality and reduced survival after a cancer diagnosis compared to people without the variant. The study estimated the variant occurs in about 1 in 571 to 1 in 940 people.
It's important to understand this was an observational study, which means it can show links but cannot prove the gene variant causes these outcomes. The researchers note that the cancer risks they found were lower than previous estimates from studies focused on families with strong cancer histories. No safety concerns were reported because this study looked at existing data rather than testing treatments.
Readers should know this research helps inform genetic counseling and screening discussions. If you have questions about genetic testing or cancer risk based on family history, speaking with a healthcare provider or genetic counselor is the best next step.
